Related Experiment Video
Updated: Jul 7, 2026

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
Published on: November 8, 2013
An adherence self-report questionnaire facilitated the differentiation between nonadherence and nonresponse to
Andreas Zeller1, Knut Schroeder, Tim J Peters
1Academic Unit of Primary Health Care, Department of Community Based Medicine, University of Bristol, Cotham House, Cotham Hill, BS6 6JL Bristol, United Kingdom. zellera@uhbs.ch
Objectives:
To evaluate, among hypertensive patients, a brief adherence self-report questionnaire (ASRQ), using electronic monitors (medical event monitoring system, MEMS) as the gold standard comparator.
Study Design And Setting:
A total of 239 patients with hypertension in five general practices in Bristol, UK completed the ASRQ before and at the end of the 4-week study period. Patients were asked to choose one of six descriptions (from level 1=perfect adherence to level 6=nonadherence) to express their medication taking. The main outcome measure was "timing adherence" (correct interdose intervals) as measured through electronic monitors.
Results:
Most patients (89%) stated perfect or nearly perfect adherence, and data from the electronic monitors showed a mean timing adherence of 88.3% (n=216). Using the cutoff of those who reported ASRQ levels 1 and 2 (all tablets taken but not always at the same time of day), a high percentage of those with comparatively high adherence according to MEMS were correctly identified (specificity, 90-93%; negative predictive value, 66-96%). However, sensitivity (detection of true nonadherers) and positive predictive value were poor to moderate (14-42% and 22-66%, respectively).
Conclusion:
The questionnaire could be a useful aid to facilitate the difficult differentiation between nonadherence and nonresponse to prescribed antihypertensive medication.
Related Concept Videos
Pre-Procedural Guidelines for Assessing Blood Pressure
Antihypertensive Drugs: Direct Renin Inhibitors
Drug Therapy
Antianxiety Medications
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Assessment of blood pressure in brachial artery(one-step method)
Prepare for the Procedure: